In a recent study, the United States Food and Drug Administration‐approved NIR dye ICG was incorporated onto Gd‐DTPA‐human serum albumin (HSA)@ICG‐NPs containing glycyrrhetinic acid‐modified Gd diethylenetriaminepentaacetic acid (Gd‐DTPA) to create the multifunctional nanoreagent Gd‐DTPA‐HSA@ICG‐bevacizumab (NPs‐Bev), a novel multifunctional self‐assembled nanoprobe with high biocompatibility and highly viable therapeutic reagents for MRI, fluorescence imaging and radiotherapy, which is expected to be a multifunctional nanoplatform for breast cancer precision therapy.78 Here, ALB is linked to breast carcinoma.